Synergistic effects of resilience and serum ghrelin levels on the 12-week pharmacotherapeutic response in patients with depressive disorders

MLA

Jae-Min Kim, et al. “Synergistic Effects of Resilience and Serum Ghrelin Levels on the 12-Week Pharmacotherapeutic Response in Patients with Depressive Disorders.” Journal of Affective Disorders, vol. 295, Dec. 2021, pp. 1489–93. EBSCOhost, https://doi.org/10.1016/j.jad.2021.09.039.

APA

Jae-Min Kim, Robert Stewart, Hee-Ju Kang, Ju-Wan Kim, Hee Kyung Kim, Sung-Wan Kim, Ho-Cheol Kang, Wonsuk Choi, & Ju-Yeon Lee. (2021). Synergistic effects of resilience and serum ghrelin levels on the 12-week pharmacotherapeutic response in patients with depressive disorders. Journal of Affective Disorders, 295, 1489–1493. https://doi.org/10.1016/j.jad.2021.09.039

Chicago

Jae-Min Kim, Robert Stewart, Hee-Ju Kang, Ju-Wan Kim, Hee Kyung Kim, Sung-Wan Kim, Ho-Cheol Kang, Wonsuk Choi, and Ju-Yeon Lee. 2021. “Synergistic Effects of Resilience and Serum Ghrelin Levels on the 12-Week Pharmacotherapeutic Response in Patients with Depressive Disorders.” Journal of Affective Disorders 295 (December): 1489–93. doi:10.1016/j.jad.2021.09.039.